VSIR and neoplasm: V-domain immunoglobulin suppressor of T-cell activation (VISTA), which was found to be overexpressed in the tumor-infiltrating lymphocytes (TILs) of NSCLC [10], might substantially regulate adaptive antitumor immunity as novel inhibitory ICs [11,12].